439 related articles for article (PubMed ID: 28559456)
1. Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.
Hart NH; Newton RU; Spry NA; Taaffe DR; Chambers SK; Feeney KT; Joseph DJ; Redfern AD; Ferguson T; Galvão DA
BMJ Open; 2017 May; 7(5):e014458. PubMed ID: 28559456
[TBL] [Abstract][Full Text] [Related]
2. Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.
Hart NH; Galvão DA; Saunders C; Taaffe DR; Feeney KT; Spry NA; Tsoi D; Martin H; Chee R; Clay T; Redfern AD; Newton RU
Trials; 2018 Dec; 19(1):695. PubMed ID: 30572928
[TBL] [Abstract][Full Text] [Related]
3. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
[TBL] [Abstract][Full Text] [Related]
4. The LIFTMOR-M (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation for Men) trial: protocol for a semirandomised controlled trial of supervised targeted exercise to reduce risk of osteoporotic fracture in older men with low bone mass.
Harding AT; Weeks BK; Watson SL; Beck BR
BMJ Open; 2017 Jun; 7(6):e014951. PubMed ID: 28611110
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial.
Galvão DA; Taaffe DR; Cormie P; Spry N; Chambers SK; Peddle-McIntyre C; Baker M; Denham J; Joseph D; Groom G; Newton RU
BMC Cancer; 2011 Dec; 11():517. PubMed ID: 22166044
[TBL] [Abstract][Full Text] [Related]
6. Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.
Galvão DA; Hayne D; Frydenberg M; Chambers SK; Taaffe DR; Spry N; Scuffham PA; Ware RS; Hart NH; Newton RU
BMJ Open; 2018 Apr; 8(4):e022331. PubMed ID: 29678994
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.
Cormie P; Newton RU; Spry N; Joseph D; Taaffe DR; Galvão DA
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):328-35. PubMed ID: 23917308
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
9. The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial.
Sheill G; Brady L; Guinan E; Hayes B; Casey O; Greene J; Vlajnic T; Cahill F; Van Hemelrijck M; Peat N; Rudman S; Hussey J; Cunningham M; Grogan L; Lynch T; Manecksha RP; McCaffrey J; Mucci L; Sheils O; O'Leary J; O'Donnell DM; McDermott R; Finn S
Trials; 2017 Oct; 18(1):456. PubMed ID: 28978344
[TBL] [Abstract][Full Text] [Related]
10. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).
Galvão DA; Taaffe DR; Hayne D; Lopez P; Lyons-Wall P; Tang CI; Chambers SK; Devine A; Spry N; Jeffery E; Kudiarasu C; Joseph D; Newton RU
BMJ Open; 2022 Jun; 12(6):e058899. PubMed ID: 35667725
[TBL] [Abstract][Full Text] [Related]
11. Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases.
Galvão DA; Taaffe DR; Spry N; Cormie P; Joseph D; Chambers SK; Chee R; Peddle-McIntyre CJ; Hart NH; Baumann FT; Denham J; Baker M; Newton RU
Med Sci Sports Exerc; 2018 Mar; 50(3):393-399. PubMed ID: 29036016
[TBL] [Abstract][Full Text] [Related]
12. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: a randomised, double-blind, placebo-controlled trial.
Fairman CM; Kendall KL; Newton RU; Hart NH; Taaffe DR; Chee R; Tang CI; Galvão DA
BMJ Open; 2019 Sep; 9(9):e030080. PubMed ID: 31542747
[TBL] [Abstract][Full Text] [Related]
13. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol.
Newton RU; Kenfield SA; Hart NH; Chan JM; Courneya KS; Catto J; Finn SP; Greenwood R; Hughes DC; Mucci L; Plymate SR; Praet SFE; Guinan EM; Van Blarigan EL; Casey O; Buzza M; Gledhill S; Zhang L; Galvão DA; Ryan CJ; Saad F
BMJ Open; 2018 May; 8(5):e022899. PubMed ID: 29764892
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial.
Luo H; Galvão DA; Newton RU; Tang C; Dean A; Jasas K; Johansson M; Yusoff I; Spry N; Taaffe DR
BMJ Open Gastroenterol; 2021 Jun; 8(1):. PubMed ID: 34099463
[TBL] [Abstract][Full Text] [Related]
15. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
[TBL] [Abstract][Full Text] [Related]
16. Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.
Østergren P; Ragle AM; Jakobsen H; Klausen TW; Vinther A; Sønksen J
BMJ Open; 2016 Jun; 6(6):e011460. PubMed ID: 27357198
[TBL] [Abstract][Full Text] [Related]
17. Strength Training for Adolescents with cerebral palsy (STAR): study protocol of a randomised controlled trial to determine the feasibility, acceptability and efficacy of resistance training for adolescents with cerebral palsy.
Ryan JM; Theis N; Kilbride C; Baltzopoulos V; Waugh C; Shortland A; Lavelle G; Noorkoiv M; Levin W; Korff T
BMJ Open; 2016 Oct; 6(10):e012839. PubMed ID: 27707836
[TBL] [Abstract][Full Text] [Related]
18. Modular multimodal hospital-home chain physical activity rehabilitation programme (3M2H-PARP) in liver cancer: a protocol for a randomised controlled trial.
Chen H; Lu H; Zhou H; Wu B; Dong Z; Zhang S; Gu Y; Zhou G; Xiang J; Yang J
BMJ Open; 2024 May; 14(5):e083228. PubMed ID: 38772899
[TBL] [Abstract][Full Text] [Related]
19. Exercise training in the treatment of paroxysmal atrial fibrillation: study protocol of the Cologne ExAfib Trial.
Zacher J; Dillschnitter K; Freitag N; Kreutz T; Bjarnason-Wehrens B; Bloch W; Predel HG; Schumann M
BMJ Open; 2020 Oct; 10(10):e040054. PubMed ID: 33130570
[TBL] [Abstract][Full Text] [Related]
20. i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol.
Hyatt A; Gough K; Murnane A; Au-Yeung G; Dawson T; Pearson E; Dhillon H; Sandhu S; Williams N; Paton E; Billett A; Traill A; Andersen H; Beedle V; Milne D
BMJ Open; 2020 Feb; 10(2):e036059. PubMed ID: 32114479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
